carmot glp-1 Therapeutics starts phase 2 trial for CT-868, a GLP-1/GIP agonist, to treat Type 1 Diabetes Roche's $2.7B Carmot bet pays

Nevertheless, the safety of natural products should be evaluated cautiously (Fan et al., 2026)

In a symposium at ADA that I was a speaker at, we highlighted Amylin as a interesting therapeutic target in both obesity as well as in obesity with Type 2 diabetes

PlexusDx adds no membership fee and operates in all 50 states (five require a scheduled live consultation rather than async intake)

Sometimes people get bored with just focusing on water

Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor--expressing cells in the nucleus tractus solitarius of ovariectomized rats

Triggering innate and adaptive responses To stimulate adaptive immunity, a vaccine requires a pathogen-specific immunogen as well as an adjuvant the latter stimulates the innate immune system and provides the necessary second signal for T cell activation